Active	Status	Sponsor type	Region	Phase	Filter
10 Active 3 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
VERGER, Antoine
NCT04265209 / 2019-000247-27: [18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor	Recruiting	3	152	Europe	SPECT, PET	Zionexa	Parkinson Disease, Essential Tremor	09/24	12/24
KING, NCT05512403: Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics	Recruiting	3	88	Europe	PET/CT with 18F-DOPA	Central Hospital, Nancy, France	Glioma	12/25	10/26
ELUMEN, NCT06126588: Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial	Recruiting	2	28	Europe	Everolimus	Central Hospital, Nancy, France	Meningioma	03/26	05/28
DAPSYFIX, NCT05683665: DaTSCAN Brain Scintigraphy and Psychotropic Treatments: Influence on Radiotracer Binding	Completed	N/A	300	Europe	scintigraphy DaTSCAN	Central Hospital, Nancy, France	Parkinson Disease	06/23	07/23
OEN, NCT05994768: 18F-FDG Tomography and Labeled Leukocyte Scintigraphy	Completed	N/A	18	Europe	18F-FDG PET/CT, scintigraphy with labeled leukocytes	Central Hospital, Nancy, France	Malignant Otitis Externa	07/23	10/23
TEP-COV, NCT04764721: Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19	Completed	N/A	25	Europe	18F-FDG PET-CT	Central Hospital, Nancy, France	Covid-19	08/23	11/23
MELUTE, NCT06255249: Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide	Not yet recruiting	N/A	50	NA		Central Hospital, Nancy, France	Meningioma	12/24	03/25
ATEPDIPSY, NCT06463093: Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative Origin	Recruiting	N/A	20	Europe		Central Hospital, Nancy, France	Neurocognitive Disorders	01/25	07/25
PADL, NCT06268418: Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy	Recruiting	N/A	46	Europe	Artificial intelligence	Central Hospital, Nancy, France	Radionucleide Therapy	04/25	06/25
DORA, NCT04766632: Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas	Recruiting	N/A	20	Europe	Brain PET-CT of 18F-DOPA	Central Hospital, Nancy, France	High Grade Glioma	05/25	12/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
VERGER, Antoine
NCT04265209 / 2019-000247-27: [18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor	Recruiting	3	152	Europe	SPECT, PET	Zionexa	Parkinson Disease, Essential Tremor	09/24	12/24
KING, NCT05512403: Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics	Recruiting	3	88	Europe	PET/CT with 18F-DOPA	Central Hospital, Nancy, France	Glioma	12/25	10/26
ELUMEN, NCT06126588: Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial	Recruiting	2	28	Europe	Everolimus	Central Hospital, Nancy, France	Meningioma	03/26	05/28
DAPSYFIX, NCT05683665: DaTSCAN Brain Scintigraphy and Psychotropic Treatments: Influence on Radiotracer Binding	Completed	N/A	300	Europe	scintigraphy DaTSCAN	Central Hospital, Nancy, France	Parkinson Disease	06/23	07/23
OEN, NCT05994768: 18F-FDG Tomography and Labeled Leukocyte Scintigraphy	Completed	N/A	18	Europe	18F-FDG PET/CT, scintigraphy with labeled leukocytes	Central Hospital, Nancy, France	Malignant Otitis Externa	07/23	10/23
TEP-COV, NCT04764721: Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19	Completed	N/A	25	Europe	18F-FDG PET-CT	Central Hospital, Nancy, France	Covid-19	08/23	11/23
MELUTE, NCT06255249: Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide	Not yet recruiting	N/A	50	NA		Central Hospital, Nancy, France	Meningioma	12/24	03/25
ATEPDIPSY, NCT06463093: Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative Origin	Recruiting	N/A	20	Europe		Central Hospital, Nancy, France	Neurocognitive Disorders	01/25	07/25
PADL, NCT06268418: Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy	Recruiting	N/A	46	Europe	Artificial intelligence	Central Hospital, Nancy, France	Radionucleide Therapy	04/25	06/25
DORA, NCT04766632: Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas	Recruiting	N/A	20	Europe	Brain PET-CT of 18F-DOPA	Central Hospital, Nancy, France	High Grade Glioma	05/25	12/25